Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
about
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagyBreast Cancer-Associated Fibroblasts: Where We Are and Where We Need to GoNeuropilins: expression and roles in the epitheliumCancer-associated fibroblasts in digestive tumorsDrug development against metastasis-related genes and their pathways: A rationale for cancer therapyDiagnosis of hepatocellular carcinoma.Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications.Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.Expression of growth factor receptors and targeting of EGFR in cholangiocarcinoma cell lines.Preclinical efficacy of the c-Met inhibitor CE-355621 in a U87 MG mouse xenograft model evaluated by 18F-FDG small-animal PET.From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways.HGF and c-Met interaction promotes migration in human chondrosarcoma cellsEpigallocatechin-3-gallate inhibits paracrine and autocrine hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion.Prognostic and survival factors in myxofibrosarcomas.Cancer-associated fibroblasts from hepatocellular carcinoma promote malignant cell proliferation by HGF secretionHepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail.Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonistAssociation of hepatocyte-derived growth factor receptor/caudal type homeobox 2 co-expression with mucosal regeneration in active ulcerative colitisThe HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in MelanomaYangZheng XiaoJi exerts anti-tumour growth effects by antagonising the effects of HGF and its receptor, cMET, in human lung cancer cells.Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.Hepatocyte growth factor induces epithelial cell motility through transactivation of the epidermal growth factor receptor.Isolation and characterization of anti c-met single chain fragment variable (scFv) antibodies.Importance of the brain Angiotensin system in Parkinson's diseaseBacterial entry into cells: a role for the endocytic machinery.Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancerImportance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro.DNA triplex-mediated inhibition of MET leads to cell death and tumor regression in hepatoma.Signal transduction of fertilization in frog eggs and anti-apoptotic mechanism in human cancer cells: common and specific functions of membrane microdomains.Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.Hepatocyte growth factor promotes proliferation, invasion, and metastasis of myeloid leukemia cells through PI3K-AKT and MAPK/ERK signaling pathwayCritical signal transduction pathways in CLL.Dual roles of protein tyrosine phosphatase kappa in coordinating angiogenesis induced by pro-angiogenic factors.The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.Cell surface remodeling by plasmin: a new function for an old enzyme.Molecular targets for treatment of kidney fibrosis.Interaction of actinomycin D with promoter element of c-met and its inhibitory effect on the expression of c-Met.VEGF overexpression is a valuable prognostic factor for non-Hodgkin's lymphoma evidence from a systemic meta-analysis.
P2860
Q24294894-CAB1EA7C-4CC3-4F0E-BE19-5974B429EECBQ26772925-E076F822-5E0C-42A1-B41C-6B4D6598098FQ26998786-8DAF81BF-BE35-4805-ABDF-7EBF6D731B19Q27022816-D0D6663E-0051-4DF3-B4FC-5345504F7B45Q29010479-524A0ECC-4AE2-4D1D-971A-69934D147097Q30490554-32F75D64-2F39-4148-8C00-AF21529A7570Q31099702-02A6686C-E0B1-44DB-807A-117EF6BD3C36Q33529782-AD3A35D4-5D49-419F-95DE-09BA89236213Q33611056-B7C38532-CCA4-43C4-A71A-4857D2627F24Q34164758-03980AB9-C1CA-494D-880D-19DAAAF8AE89Q34389709-555BFF37-9D0A-4B8A-B86B-C69E174F3805Q34548365-40614C77-23C3-4B9F-8C96-12D17AAD911BQ34616966-2FE41870-F94B-4039-9327-215CA0C9A4B6Q34639670-164EC592-5C02-4DEF-85FC-852F125A51BFQ34718091-259495FE-DDE4-4CB1-83CB-6D5DF514406EQ34972866-7836C887-282F-4644-AB58-BC2CE44EAC6AQ35201636-203A4DFD-00E5-4AFD-8A5A-842093B2A323Q35689753-5C7F20ED-3F0C-4176-912B-8D872DEC8375Q35729065-35BA62D5-EE82-4C1D-BCA3-BE186072B81FQ35740444-D3D13076-84BB-4CA1-9F75-12412AF1DE15Q35956303-24F2573A-052A-4ED2-813C-B3EFD959F679Q36000921-6D6DB492-E4DA-448B-AD62-9D62A0029BC3Q36202958-E0F324FB-56C0-4F5C-A368-3FDFAB4074FFQ36248725-35B3A224-4E8F-4EE8-9F50-C8E740A6E811Q36250366-D2C304B7-F378-43E6-87A4-4DFF716BC99BQ36415423-C5C71285-CE6A-4C02-9620-DDB89571451BQ36464725-4507F30C-0A66-4022-B34C-BAE9989F6BB7Q36547939-2E392227-CD48-4AC8-ADDB-CCF4C0111999Q36571484-BC81AE7D-E843-4691-A969-BFDD6E49D2DCQ36868117-8FB94D01-B7C1-448D-A7AE-7CBB338BB502Q36944110-C20A43E7-FA49-4882-B7FA-CBED29C4034BQ37045324-67DEF356-B40A-4A86-B67D-5DF9259A9EA0Q37293109-55F805C0-49B6-4888-8F1E-11EF4A2E40B5Q37571068-10878BAE-CA68-496C-A4B3-E65DDA853758Q37718673-446940D3-9DED-4156-A989-9E66BA0B24E9Q38005611-F70F288A-6A4F-47CA-AC16-38DEB3B440FDQ38055477-FDC5C4F3-817E-4AD2-BA6E-040F606711B7Q38062404-CF8A7FEA-AC5D-403B-9F46-CBEFE2588E55Q38356393-E5A9C6FF-B362-4EFE-A2CD-7CD5BBB4F76AQ38391574-0CF16B19-9806-4301-8AD2-113174FA71C8
P2860
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
@ast
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
@en
type
label
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
@ast
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
@en
prefLabel
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
@ast
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
@en
P2093
P1476
Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.
@en
P2093
Christian Parr
Gaynor Davies
Kunio Matsumoto
Toshikazu Nakamura
Tracey A Martin
Wen G Jiang
P356
10.1016/J.CRITREVONC.2004.09.004
P577
2005-01-01T00:00:00Z